ACS
IART icon

Archford Capital Strategies’s Integra LifeSciences IART Stock Holding History

Archford Capital Strategies’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-396
Closed -$7.62K – 765
2014
Q2 		$7.62K Hold
396
– – 0.01% 454
2014
Q1 		$7.45K Buy
+396
New +$7.64K 0.01% 477

Other funds holding IART

ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VNIM
Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Archford Capital Strategies's IART Position: Q3 2014 in Review

Archford Capital Strategies sold out of Integra LifeSciences (IART) in Q3 2014, closing a stake of 396 shares — an estimated $7.62K sold.

Archford Capital Strategies first reported a position in IART in Q1 2014 and held it in 2 quarters. The position peaked at $7.62K in Q2 2014. 143 funds tracked by Wall St. Rank hold IART as of Q3 2014.

  • Archford Capital Strategies reported no remaining Integra LifeSciences position as of Q3 2014 after selling out during the quarter.
  • Archford Capital Strategies sold 396 Integra LifeSciences shares in Q3 2014, an estimated $7.62K.
  • Archford Capital Strategies first reported a position in Integra LifeSciences in Q1 2014 and held it in 2 quarters.
  • Archford Capital Strategies's Integra LifeSciences position peaked at $7.62K in Q2 2014.
  • 143 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2014.

Based on Archford Capital Strategies's 13F filing for Q3 2014, filed 16 Oct 2014.